Zomagen Biosciences Belgium
0744.519.837 · rovalta.com · 26/09/2026
Zomagen Biosciences Belgium
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOZomagen Biosciences Belgium is a Private limited company incorporated in 2020. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 6,2 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0744.519.837
- Incorporation
- 27/02/2020
- Legal form
- Private limited company
- Registered office
- Technologiepark-Zwijnaarde 94
9052 Gent · FlandreSee on map - Contributed capital
- 80 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 6,2 ETP
Joint committees (1)
- 207
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,2 M € | +28.0% | 910,9 k € | -5.6% | 964,8 k € | +76.5% | 546,6 k € | -30.0% | 780,7 k € |
| EBITDA | 174,4 k € | +16.9% | 149,2 k € | -1.5% | 151,5 k € | +91.4% | 79,1 k € | -44.0% | 141,3 k € |
| Operating result | 147 k € | +20.2% | 122,3 k € | -1.8% | 124,6 k € | +141% | 51,8 k € | -59.0% | 126,2 k € |
| Net result | 87,4 k € | +1.8% | 85,9 k € | +4.2% | 82,4 k € | +64.6% | 50,1 k € | -38.8% | 81,8 k € |
| Balance sheet | |||||||||
| Equity | 467,6 k € | +23.0% | 380,1 k € | +29.2% | 294,3 k € | +38.9% | 211,9 k € | +30.9% | 161,8 k € |
| Total assets | 1,8 M € | +30.1% | 1,4 M € | +0.9% | 1,4 M € | -40.3% | 2,3 M € | +69.0% | 1,4 M € |
| Cash | 157,8 k € | +293% | 40,2 k € | -60.8% | 102,4 k € | -75.5% | 417,8 k € | +153% | 165,1 k € |
| Debts | 1,4 M € | +32.7% | 1 M € | -1.3% | 1 M € | -50.9% | 2,1 M € | +74.1% | 1,2 M € |
| Other | |||||||||
| Workforce | 6,2 ETP | +12.7% | 5,5 ETP | +22.2% | 4,5 ETP | +15.4% | 3,9 ETP | – | |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Ended mandates
Other companies at this address
Technologiepark-Zwijnaarde 94 9052 Gent| Company | CBE no. |
|---|---|
AnimAb● Active | 0747.674.614 |
BioLyo Technologies● Active | 0741.579.648 |
ExeVir Bio● Active | 0750.495.334 |
Flindr Labs● Active | 1014.117.578 |
Protealis● Active | 0765.251.410 |
| 0873.953.667 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/02/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 23 months |
| Filing date | 06/07/2026 | 27/06/2025 | 02/07/2024 | 30/06/2023 | 05/07/2022 |
| General meeting | 04/06/2026 | 05/06/2025 | 27/06/2024 | 01/06/2023 | 04/07/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 5 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 04/06/2026 | 06/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 05/06/2025 | 27/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 27/06/2024 | 02/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 01/06/2023 | 30/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 04/07/2022 | 05/07/2022 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates03/09/2026Ontslag bestuurder - benoeming bestuurders - ontslag persoon belast met
- Mandates28/02/2024ONTSLAGEN - BENOEMINGEN
- Mandates13/02/2024ONTSLAGEN - BENOEMINGEN
- Mandates17/08/2022ONTSLAGEN - BENOEMINGEN
- Mandates22/10/2021ONTSLAGEN - BENOEMINGEN
- Registered office31/08/2021MAATSCHAPPELIJKE ZETEL
- Other10/06/2021ALGEMENE VERGADERING - BOEKJAAR
- Mandates08/05/2020ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202587,4 k €↑
- 2024Annual accounts 202485,9 k €↑
- 2023Annual accounts 202382,4 k €↑
- 2022Annual accounts 202250,1 k €↓
- 2021Annual accounts 202181,8 k €
- 27/02/2020IncorporationPrivate limited company